Abstract Objective Interleukin (IL)-22 is a potential therapeutic protein for the treatment of
metabolic diseases such as obesity, type 2 diabetes, and metabolic dysfunction-associated …

Abstract Background Interleukin-22 (IL-22), a cytokine with important functions in anti-
microbial defense and tissue repair, has been recently suggested to have beneficial effects …

BACKGROUND & AIMS: Interleukin-22 (IL-22) is a Th17-related cytokine within the IL-10
family and plays an important role in host defense and inflammatory responses in …

The incidence of metabolic syndrome continues to rise globally. In mice, intravenous
administration of interleukin-22 (IL-22) ameliorates various disease phenotypes associated …

Hepatocellular injury, a pivotal contributor to liver diseases, particularly hepatitis, lacks
effective pharmacological treatments. Interleukin‐22 (IL‐22), crucial for liver cell survival …

We investigated potential pathophysiological relationships between interleukin 18 (IL-18)
and dyslipidemia, nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis …

Obesity and associated metabolic diseases are characterized by a chronic low-grade
inflammatory state with the infiltration of many inflammatory cells, especially macrophages …

The therapeutic effect of liposomal IL-22 versus non-liposomal IL-22 on liver fibrosis was
investigated. IL-22 (5 µg/ml) was incorporated into negative charged liposomes …

To investigate the relationship between interleukin‐17 and proteins involved in fatty acid
metabolism with respect to alcoholic liver disease, male ICR mice were randomized into five …

Non-alcoholic fatty liver disease (NAFLD) is a hepatic presentation of obesity and metabolic
syndrome. MicroRNA 26a (Mir-26a) has been reported to play functions in cellular …